Back to all studies
RecruitingNCT06990191

A Hybrid 1 Effectiveness-Implementation study of Partner-Assisted Prolonged Exposure for PTSD

This study is recruiting. It focuses on PTSD and currently lists participation information in the United States.

PTSDBehavioralOver 18 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06990191. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether Partner-Assisted Prolonged Exposure may be useful for adults experiencing ptsd.

What would participation involve?

Participants may receive Partner-Assisted Prolonged Exposure, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in United States.

Who is it mainly for?

This study appears to be mainly for adults with ptsd.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Estimated enrollment
420
Sponsor
United States Department of Defense
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06990191
Official title
A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06990191. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help test a support approach in real life.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: PTSD occurs in up to 17% of post-9/11 US Service Members and is associated with long-term functional impairment, family problems, unemployment, and suicidality. Trauma-focused therapies (TFTs), such as Prolonged Exposure (PE), result in significant relief for many. Yet, TFTs. The study team can confirm the exact objective and what it means for you.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving Partnered Prolonged Exposure (PPE), Prolonged Exposure (PE). Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with ptsd; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

Does a loved one or caregiver need to be involved?

The public registry appears to mention a loved one, caregiver, or family involvement. Ask whether that person must participate, provide information, attend visits, or simply be available if needed. The study team must confirm what is required.

Will I need to change, stop, or stabilize my current treatment?

The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by United States Department of Defense, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps. The registry lists an estimated enrollment of 420 participants.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me